Cargando…

Rationale and design for studying organisation of care for intra-arterial thrombectomy in the Netherlands: simulation modelling study

INTRODUCTION: The introduction of intra-arterial thrombectomy (IAT) challenges acute stroke care organisations to provide fast access to acute stroke therapies. Parameters of pathway performance include distances to primary and comprehensive stroke centres (CSCs), time to treatment and availability...

Descripción completa

Detalles Bibliográficos
Autores principales: Lahr, Maarten M H, Maas, Willemijn J, van der Zee, Durk-Jouke, Uyttenboogaart, Maarten, Buskens, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955572/
https://www.ncbi.nlm.nih.gov/pubmed/31915166
http://dx.doi.org/10.1136/bmjopen-2019-032754
_version_ 1783486959962816512
author Lahr, Maarten M H
Maas, Willemijn J
van der Zee, Durk-Jouke
Uyttenboogaart, Maarten
Buskens, Erik
author_facet Lahr, Maarten M H
Maas, Willemijn J
van der Zee, Durk-Jouke
Uyttenboogaart, Maarten
Buskens, Erik
author_sort Lahr, Maarten M H
collection PubMed
description INTRODUCTION: The introduction of intra-arterial thrombectomy (IAT) challenges acute stroke care organisations to provide fast access to acute stroke therapies. Parameters of pathway performance include distances to primary and comprehensive stroke centres (CSCs), time to treatment and availability of ambulance services. Further expansion of IAT centres may increase treatment rates yet could affect efficient use of resources and quality of care due to lower treatment volume. The aim was to study the organisation of care and patient logistics of IAT for patients with ischaemic stroke in the Netherlands. METHODS AND ANALYSES: Using a simulation modelling approach, we will quantify performance of 16 primary and CSCs offering IAT in the Netherlands. Patient data concerning both prehospital and intrahospital pathway logistics will be collected and used as input for model validation. A previously validated simulation model for intravenous thrombolysis (IVT) patients will be expanded with data of the MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands) Registry and trials performed in the Collaboration for New Treatments in Acute Stroke consortium to represent patient logistics, time delays and outcomes in IAT patients. Simulation experiments aim to assess effectiveness and efficiency of alternative network topologies, that is, IAT with or without IVT at the nearest primary stroke centre (PSC) versus centralised care at a CSC. Primary outcomes are IAT treatment rates and clinical outcome according to the modified Rankin Scale. Secondary outcomes include onset-to-treatment time and resource use. Mann-Whitney U and Fisher’s exact tests will be used to estimate differences for continuous and categorical variables. Model and parameter uncertainty will be tested using sensitivity analyses. ETHICS AND DISSEMINATION: This will be the first study to examine the organisation of acute stroke care for IAT delivery on a national scale using discrete event simulation. There are no ethics or safety concerns regarding the dissemination of information, which includes publication in peer-reviewed journals and (inter)national conference presentations. TRIAL REGISTRATION NUMBER: ISRCTN99503308, ISRCTN76741621, ISRCTN19922220, ISRCTN80619088, NCT03608423; Pre-results.
format Online
Article
Text
id pubmed-6955572
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-69555722020-01-27 Rationale and design for studying organisation of care for intra-arterial thrombectomy in the Netherlands: simulation modelling study Lahr, Maarten M H Maas, Willemijn J van der Zee, Durk-Jouke Uyttenboogaart, Maarten Buskens, Erik BMJ Open Neurology INTRODUCTION: The introduction of intra-arterial thrombectomy (IAT) challenges acute stroke care organisations to provide fast access to acute stroke therapies. Parameters of pathway performance include distances to primary and comprehensive stroke centres (CSCs), time to treatment and availability of ambulance services. Further expansion of IAT centres may increase treatment rates yet could affect efficient use of resources and quality of care due to lower treatment volume. The aim was to study the organisation of care and patient logistics of IAT for patients with ischaemic stroke in the Netherlands. METHODS AND ANALYSES: Using a simulation modelling approach, we will quantify performance of 16 primary and CSCs offering IAT in the Netherlands. Patient data concerning both prehospital and intrahospital pathway logistics will be collected and used as input for model validation. A previously validated simulation model for intravenous thrombolysis (IVT) patients will be expanded with data of the MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands) Registry and trials performed in the Collaboration for New Treatments in Acute Stroke consortium to represent patient logistics, time delays and outcomes in IAT patients. Simulation experiments aim to assess effectiveness and efficiency of alternative network topologies, that is, IAT with or without IVT at the nearest primary stroke centre (PSC) versus centralised care at a CSC. Primary outcomes are IAT treatment rates and clinical outcome according to the modified Rankin Scale. Secondary outcomes include onset-to-treatment time and resource use. Mann-Whitney U and Fisher’s exact tests will be used to estimate differences for continuous and categorical variables. Model and parameter uncertainty will be tested using sensitivity analyses. ETHICS AND DISSEMINATION: This will be the first study to examine the organisation of acute stroke care for IAT delivery on a national scale using discrete event simulation. There are no ethics or safety concerns regarding the dissemination of information, which includes publication in peer-reviewed journals and (inter)national conference presentations. TRIAL REGISTRATION NUMBER: ISRCTN99503308, ISRCTN76741621, ISRCTN19922220, ISRCTN80619088, NCT03608423; Pre-results. BMJ Publishing Group 2020-01-07 /pmc/articles/PMC6955572/ /pubmed/31915166 http://dx.doi.org/10.1136/bmjopen-2019-032754 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Neurology
Lahr, Maarten M H
Maas, Willemijn J
van der Zee, Durk-Jouke
Uyttenboogaart, Maarten
Buskens, Erik
Rationale and design for studying organisation of care for intra-arterial thrombectomy in the Netherlands: simulation modelling study
title Rationale and design for studying organisation of care for intra-arterial thrombectomy in the Netherlands: simulation modelling study
title_full Rationale and design for studying organisation of care for intra-arterial thrombectomy in the Netherlands: simulation modelling study
title_fullStr Rationale and design for studying organisation of care for intra-arterial thrombectomy in the Netherlands: simulation modelling study
title_full_unstemmed Rationale and design for studying organisation of care for intra-arterial thrombectomy in the Netherlands: simulation modelling study
title_short Rationale and design for studying organisation of care for intra-arterial thrombectomy in the Netherlands: simulation modelling study
title_sort rationale and design for studying organisation of care for intra-arterial thrombectomy in the netherlands: simulation modelling study
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955572/
https://www.ncbi.nlm.nih.gov/pubmed/31915166
http://dx.doi.org/10.1136/bmjopen-2019-032754
work_keys_str_mv AT lahrmaartenmh rationaleanddesignforstudyingorganisationofcareforintraarterialthrombectomyinthenetherlandssimulationmodellingstudy
AT maaswillemijnj rationaleanddesignforstudyingorganisationofcareforintraarterialthrombectomyinthenetherlandssimulationmodellingstudy
AT vanderzeedurkjouke rationaleanddesignforstudyingorganisationofcareforintraarterialthrombectomyinthenetherlandssimulationmodellingstudy
AT uyttenboogaartmaarten rationaleanddesignforstudyingorganisationofcareforintraarterialthrombectomyinthenetherlandssimulationmodellingstudy
AT buskenserik rationaleanddesignforstudyingorganisationofcareforintraarterialthrombectomyinthenetherlandssimulationmodellingstudy